Newsletter sign-up

Transatlantic Diabetic Lower Extremity Symposium, Santorini, Greece
Thursday, 18 October 2018

We look forward to attending this conference, where we have a podium and poster presentation.

Symposium of Advanced Wound Care, Las Vegas
Friday, 2 November 2018

Please come and visit us at our booth to learn more about 3C Patch. There will also be podium and poster presentations about our technology at this conference.

Innovations In Wound Healing, Key Largo
Saturday, 8 December 2018

We look forward to attending this conference, where there will be podium and poster presentations regarding 3C Patch.

< Back to overview

3C Patch® is the new name for LeucoPatch®

by Rasmus Lundquist

3C Patch Based on the positive clinical results documented in the outcome data (recently published in The Lancet Diabetes & Endocrinology) of a major international randomized controlled trial of our LeucoPatch® wound healing technology, Reapplix’s primary focus now shifts from development to commercialization.

As part of our commercialization strategy, our new global brand name for LeucoPatch® will be 3C Patch®. Over the coming months, we will transition to this new brand name, which derives from the 3 step process involved in creating a 3 layered patch (Centrifugation, Coagulation, Compaction) and provides a generic and internationally recognizable brand.

The marketing of 3C Patch®, to which Reapplix holds the patents and the global rights, has begun in Denmark.